Naoki Morishita

Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C

Y. Imai, N. Hiramatsu, T. Kodama, 2018, Hepatology communications.

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

Y. Imai, N. Hayashi, A. Kasahara, 2015, Journal of viral hepatitis.

The prospective randomized study on telaprevir at 1500 or 2250 mg with pegylated interferon plus ribavirin in Japanese patients with HCV genotype 1

Y. Imai, N. Hayashi, A. Kasahara, 2015, Journal of Gastroenterology.

Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection

Y. Imai, N. Hayashi, A. Kasahara, 2015, Journal of Gastroenterology.

Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

N. Hiramatsu, K. Imanaka, K. Ohkawa, 2023, PloS one.

Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis

N. Hiramatsu, Ryoko Yamada, T. Tatsumi, 2014, Journal of Gastroenterology.

Significance of liver stiffness measurement by acoustic radiation force impulse (ARFI) among hepatitis C patients

N. Hayashi, N. Hiramatsu, Ryoko Yamada, 2014, Journal of medical virology.

Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response

Y. Imai, N. Hayashi, N. Hiramatsu, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study

N. Hiramatsu, K. Imanaka, K. Ohkawa, 2024, PloS one.

Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all‐oral direct‐acting antivirals: Analysis of a Japanese prospective cohort

Y. Imai, K. Ohkawa, T. Kodama, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.